Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
In this protocol the investigators will test the effect of dalfampridine (a potassium channel
blocker) on genioglossus muscle activity (EMG GG) during wakefulness and sleep in healthy
control subjects.